Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos

American Journal of Clinical Nutrition

Volumn 91, Issue 3, 2010, Pages 777-785

  Makhoul, Zeina ^a   Kristal, Alan R ^a   Gulati, Roman ^a   Luick, Bret ^b   Bersamin, Andrea ^b   Boyer, Bert ^b   Mohatt, Gerald V ^b  

^a USA   (United States)

^b UNIVERSITY OF ALASKA FAIRBANKS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CHOLESTEROL; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTE; FAT INTAKE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FEMALE; HUMANS; INUITS; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 77749264470     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28820     Document Type: Article

References (78)

1. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57.
2. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.
3. Nettleton JA, Katz R. n - 3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 2005;105:428-40.
4. Fritsche K. Fatty acids as modulators of the immune response. Annu Rev Nutr 2006;26:45-73.
5. Bouwens M, van de Rest O, Dellschaft N, et al. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009;90:415-24.
6. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 2005;25:317-40.
7. Ferrucci L, Cherubini A, Bandinelli S, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006;91:439-46.
8. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008;197:821-8.
9. He K, Liu K, Daviglus ML, et al. Intakes of long-chain n - 3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr 2008;88:1111-8.
10. Motoyama KR, Curb JD, Kadowaki T, et al. Association of serum n - 6 and n - 3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men. Am J Clin Nutr 2009;90:49-55.
11. Dewailly EE, Blanchet C, Gingras S, et al. Relations between n - 3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 2001;74:603-11.
12. Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ. Cardiovascular disease risk factors and n - 3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 2002;76:85-92.
13. Dewailly E, Blanchet C, Lemieux S, et al. n - 3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 2001;74:464-73.
14. Okuda N, Ueshima H, Okayama A, et al. Relation of long chain n - 3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID Study. Atherosclerosis 2005;178:371-9.
15. Bonaa KH, Bjerve KS, Nordoy A. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: the Tromso study. Am J Clin Nutr 1992;55:1126-34.
16. Kelley DS, Siegel D, Vemuri M, Mackey BE. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007;86:324-33.
17. Leigh-Firbank EC, Minihane AM, Leake DS, et al. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Br J Nutr 2002;87:435-45.
18. Maki KC, Van Elswyk ME, McCarthy D, et al. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J Am Coll Nutr 2005;24:189-99.
19. Niu K, Hozawa A, Kuriyama S, et al. Dietary long-chain n - 3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 2006;84:223-9.
20. Bersamin A, Zidenberg-Cherr S, Stern JS, Luick BR. Nutrient intakes are associated with adherence to a traditional diet among Yup'ik Eskimos living in remote Alaska Native communities: the CANHR Study. Int J Circumpolar Health 2007;66:62-70.
21. Johnson JS, Nobmann ED, Asay E, Lanier AP. Dietary intake of Alaska native people in two regions and implications for health: the Alaska Native Dietary and Subsistence Food Assessment Project. Int J Circumpolar Health 2009;68:109-22.
22. Bersamin A, Luick BR, King IB, Stern JS, Zidenberg-Cherr S. Westernizing diets influence fat intake, red blood cell fatty acid composition, and health in remote Alaskan Native Communities in the Center for Alaska Native Health Study. J Am Diet Assoc 2008;108:266-73.
23. Boyer BB, Mohatt GV, Lardon C, et al. Building a community-based participatory research center to investigate obesity and diabetes in Alaska Natives. Int J Circumpolar Health 2005;64:281-90.
24. Mohatt GV, Plaetke R, Klejka J, et al. The Center for Alaska Native Health Research study: a community-based participatory research study of obesity and chronic disease-related protective and risk factors. Int J Circumpolar Health 2007;66:8-18.
25. Magnusardottir AR, Skuladottir GV. Effects of storage time and added antioxidant on fatty acid composition of red blood cells at -20° C. Lipids 2006;41:401-4.
26. Otto SJ, Foreman-van Drongelen MM, van Houwelingen AC, Hornstra G. Effects of storage on venous and capillary blood samples: the influence of deferoxamine and butylated hydroxytoluene on the fatty acid. alterations in red blood cell phospholipids. Clin Chem Lab Med 1997;35:907-14.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
28. 15N: a novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake. Am J Clin Nutr 2009;89:913-9.
29. Rose HG, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 1965;6:428-31.
30. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20.
31. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990;5:46-51.
32. Wood SN. Generalized additive models: an introduction with R. Boca Raton, FL: Chapman & Hall/CRC, 2006.
33. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n - 3 fatty acids in humans. Am J Clin Nutr 2006;83:1467S-76S.
34. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006;52:2265-72.
35. Brown AJ, Pang E, Roberts DCK. Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids 1991;44:103-6.
36. Mori TA, Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006;9:95-104.
37. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000;71:1085-94.
38. Bonaa KH, Bjerve KS, Nordoy A. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arterioscler Thromb Vasc Biol 1992;12:675-81.
39. Childs MT, King IB, Knopp RH. Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosahexaenoic acid. Am J Clin Nutr 1990;52:632-9.
40. Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U. Dietary α-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 2009;139:861-8.
41. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
42. Cartier A, Cote M, Lemieux I, et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr 2009;89:1307-14.
43. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
44. Isobe T, Saitoh S, Takagi S, et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 2005;153:91-8.
45. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V. Effects of n - 3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006;84:540-50.
46. Kabir M, Skurnik G, Naour N, et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 2007;86:1670-9.
47. Damsgaard CT, Frøkier H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 2008;138:1061-6.
48. Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n - 3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin conentrations in overweight to moderately obese men and women. Am J Clin Nutr 2008;87:347-53.
49. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and lowgrade inflammation in overweight adolescents. Am J Clin Nutr 2005;82:1178-84.
50. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002;76:1007-15.
51. Blonk MC, Bilo HJ, Nauta JJ, Popp-Snijders C, Mulder C, Donker AJ. Dose-response effects of fish-oil supplementation in healthy volunteers. Am J Clin Nutr 1990;52:120-7.
52. Murphy KJ, Meyer BJ, Mori TA, et al. Impact of foods enriched with n - 3 long-chain polyunsaturated fatty acids on erythrocyte n - 3 levels and cardiovascular risk factors. Br J Nutr 2007;97:749-57.
53. Williams CM, Moore F, Morgan L, Wright J. Effects of n - 3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. Br J Nutr 1992;68:655-66.
54. Garg ML, Blake RJ, Clayton E, et al. Consumption of an n - 3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II. Eur J Clin Nutr 2007;61:1312-7.
55. Schwellenbach LJ, Olson KL, McConnell KJ, Stolcpart RS, Nash JD, Merenich JA. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr 2006;25:480-5.
56. Visioli F, Rise P, Plasmati E, Pazzucconi F, Sirtori CR, Galli C. Very low intakes of n - 3 fatty acids incorporated into bovine milk reduce plasma triacylglycerol and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res 2000;41:571-6.
57. Boberg M, Pollare T, Siegbahn A, Vessby B. Supplementation with n - 3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1992;22:645-50.
58. Luo J, Rizkalla SW, Vidal H, et al. Moderate intake of n - 3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Diabetes Care 1998;21:717-24.
59. Sirtori CR, Crepaldi G, Manzato E, et al. One-year treatment with ethyl esters of n - 3 fatty acids in patients with hypertriglyceridemia and glucose intolerance-Reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis 1998;137:419-27.
60. Fujioka S, Hamazaki K, Itomura M, et al. The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects - a randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol (Tokyo) 2006;52:261-5.
61. Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE, Sanders TA. LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr 2004;79:558-63.
62. de Roos B, Geelen A, Ross K, et al. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics 2008;8:1965-74.
63. Bhathena SJ, Berlin E, Judd JT, et al. Effects of omega 3 fatty acids and vitamin E on hormones involved in carbohydrate and lipid metabolism in men. Am J Clin Nutr 1991;54:684-8.
64. Fernandez-Real JM, Broch M, Vendrell J, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003;26:1362-8.
65. Lopez-Garcia E, Schulze MB, Manson JAE, et al. Consumption of (n - 3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134:1806-11.
66. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n - 3 and n - 6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155-60.
67. Yusof HM, Miles EA, Calder P. Influence of very long-chain n - 3 fatty acids on plasma markers of inflammation in middle-aged men. Prostaglandins Leukot Essent Fatty Acids 2008;78:219-28.
68. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003;35:772-81.
69. Yoneyama S, Miura K, Sasaki S, et al. Dietary intake of fatty acids and serum C-reactive protein in Japanese. J Epidemiol 2007;17:86-92.
70. Zampelas A, Panagiotakos DB, Pitsavos C, et al. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA Study. J Am Coll Cardiol 2005;46:120-4.
71. Ciubotaru I, Lee YS, Wander RC. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003;14:513-21.
72. Kelley DS, Siegel D, Fedor DM, Adkins Y, Mackey BE. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009;139:495-501.
73. Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n - 3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis 2009;205:538-43.
74. Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr 2007;17:296-304.
75. Madsen T, Christensen JH, Blom M, Schmidt EB. The effect of dietary n - 3 fatty acids on serum concentrations of C-reactive protein: a dose - response study. Br J Nutr 2003;89:517-22.
76. Geelen A, Brouwer IA, Schouten EG, Kluft C, Katan MB, Zock PL. Intake of n - 3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr 2004;58:1440-2.
77. Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients a pilot study. Nephrol Dial Transplant 2007;22:3561-7.
78. Boyer BB, Mohatt GV, Plaetke R, et al. Metabolic syndrome in Yup'ik Eskimos: The Center for Alaska Native Health Research (CANHR) Study. Obesity (Silver Spring) 2007;15:2535-40.